Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

Testosterone and dihydrotestosterone have similar effects on body composition and metabolic health in men.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

A new mutation in the STS gene causes X-linked ichthyosis, even in rare female cases.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

Targeting glycolysis may help treat PCOS by improving insulin sensitivity and ovarian function.

Women with PCOS often experience mental health issues like depression and anxiety.

SGLT2 inhibitors may help manage PCOS symptoms effectively.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

A new method accurately measures DHEAS in blood, improving on current tests.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Dermal papilla cells are key to fine wool growth in sheep.

Skin aging can be slowed by targeting cells, hormones, and the microbiome.

Women with hair loss had lower IGF-1 levels.

Testosterone therapy improved symptoms in a woman with congenital adrenal hyperplasia.

High-dose radioactive iodine therapy does not harm fertility in thyroidectomy patients.

Neurosteroids like neuro-estrogen and neuro-androgen are crucial for brain function and can improve cognition and protect against aging-related decline.

The procedure accurately measures 5-alpha-dihydrotestosterone in blood, useful for standard tests.

Skin symptoms often reveal hormonal imbalances in PCOS.